Jefferies Group LLC Adaptive Biotechnologies Corp Call Options Transaction History

Jefferies Group LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 16, 2022	SELL	$10.12 - $28.9 $289,432 - $826,540	-28,600 Closed	0 $0
Q3 2021 Sep 21, 2023	BUY	$30.02 - $39.87 $858,572 - $1.14 Million	28,600 New	28,600 $972,000
Q3 2021 Nov 15, 2021	BUY	$30.02 - $39.87 $858,572 - $1.14 Million	28,600 New	28,600 $972,000
Q4 2019 Feb 13, 2020	SELL	$24.56 - $32.8 $240,688 - $321,440	-9,800 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$30.31 - $53.51 $297,038 - $524,398	9,800 New	9,800 $303,000

202

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $812M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.